Unknown

Dataset Information

0

Structure-activity relationships of pyrazole-4-carbodithioates as antibacterials against methicillin-resistant Staphylococcus aureus.


ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of serious hospital-acquired infections and is responsible for significant morbidity and mortality in residential care facilities. New agents against MRSA are needed to combat rising resistance to current antibiotics. We recently reported 5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC) as a new bacteriostatic agent against MRSA that appears to act via a novel mechanism. Here, twenty nine analogs of HMPC were synthesized, their anti-MRSA structure-activity relationships evaluated and selectivity versus human HKC-8 cells determined. Minimum inhibitory concentrations (MIC) ranged from 0.5 to 64??g/mL and up to 16-fold selectivity was achieved. The 4-carbodithioate function was found to be essential for activity but non-specific reactivity was ruled out as a contributor to antibacterial action. The study supports further work aimed at elucidating the molecular targets of this interesting new class of anti-MRSA agents.

SUBMITTER: Majed H 

PROVIDER: S-EPMC6225992 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-activity relationships of pyrazole-4-carbodithioates as antibacterials against methicillin-resistant Staphylococcus aureus.

Majed Hiwa H   Johnston Tatiana T   Kelso Celine C   Monachino Enrico E   Jergic Slobodan S   Dixon Nicholas E NE   Mylonakis Eleftherios E   Kelso Michael J MJ  

Bioorganic & medicinal chemistry letters 20181003 22


Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of serious hospital-acquired infections and is responsible for significant morbidity and mortality in residential care facilities. New agents against MRSA are needed to combat rising resistance to current antibiotics. We recently reported 5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC) as a new bacteriostatic agent against MRSA that appears to act via a novel mechanism. Here, twenty nine analogs of HMPC were synt  ...[more]

Similar Datasets

| S-EPMC4963016 | biostudies-literature
| S-EPMC5045767 | biostudies-literature
| S-EPMC7187613 | biostudies-literature
| S-EPMC6345161 | biostudies-literature
| S-EPMC4026384 | biostudies-literature
| S-EPMC6801822 | biostudies-other
| S-EPMC8347611 | biostudies-literature
| S-EPMC7460474 | biostudies-literature
| S-EPMC2889693 | biostudies-literature
| S-EPMC5491540 | biostudies-literature